
Leucine helps pharmaceutical manufacturers remain audit-ready and ensure right-first-time batch releases by applying AI to regulated manufacturing workflows. It uses a proprietary LLM-based framework, Leucine10x, that provides specialized AI co-pilots for digitizing SOPs, creating a digital twin of the shop floor, dynamic production planning, and accelerating root-cause analysis across QA, QC, and Production. The product is a B2B SaaS compliance and manufacturing execution adjunct that targets manufacturers of small molecules, biologics, gene therapies, and vaccines. Leucine analyzes text records, logs, and interview transcripts to surface patterns and deviations from cGMP and supports compliance across material receipt to batch release. The platform is deployed at over 50 companies across 300 manufacturing facilities in 10 countries.

Leucine helps pharmaceutical manufacturers remain audit-ready and ensure right-first-time batch releases by applying AI to regulated manufacturing workflows. It uses a proprietary LLM-based framework, Leucine10x, that provides specialized AI co-pilots for digitizing SOPs, creating a digital twin of the shop floor, dynamic production planning, and accelerating root-cause analysis across QA, QC, and Production. The product is a B2B SaaS compliance and manufacturing execution adjunct that targets manufacturers of small molecules, biologics, gene therapies, and vaccines. Leucine analyzes text records, logs, and interview transcripts to surface patterns and deviations from cGMP and supports compliance across material receipt to batch release. The platform is deployed at over 50 companies across 300 manufacturing facilities in 10 countries.
What they do: AI-enabled SaaS that digitizes SOPs and ensures audit-ready pharma manufacturing (eBMRs, root-cause analysis, production planning)
Customers / scale: Deployed at over 50 companies across ~300 manufacturing facilities in 10 countries
Founded / HQ: Founded 2019; headquartered in New York
Funding: Raised $7M Series A (Oct 2023) led by Ecolab; total funding reported ~$8.12M
Pharmaceutical manufacturing compliance and quality assurance (cGMP adherence, batch release, deviation analysis).
2019
Biotechnology
7000000
Participants included Pravega Ventures, Axilor Ventures, Techstars and angel investors
“Strategic investor participation from Ecolab”